Advanced in Heart Failure

Paul C. Jansz

St Vincent's Hospital, 
Darlinghurst, NSW, AU 
Advanced in Heart Failure
St Vincent's Hospital, 
Darlinghurst, NSW, AU 
OverviewLocationsClinical Research

Overview

Paul Jansz practices in Darlinghurst, Australia. Mr. Jansz is rated as an Advanced expert by MediFind in the treatment of Heart Failure. His top areas of expertise are Heart Failure, Mitral Valve Regurgitation, Subvalvular Aortic Stenosis, Heart Transplant, and Lung Transplant.

His clinical research consists of co-authoring 101 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 41 articles and participated in 1 clinical trial in the study of Heart Failure.

Gender
Male

Locations

St Vincent's Hospital, Darlinghurst, NSW, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement
Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement
Enrollment Status: Active_not_recruiting
Publish Date: May 01, 2025
Intervention Type: Device
Study Phase: Not Applicable
Antiplatelet Removal and HemocompatIbility EventS With the HeartMate 3 Pump IDE Study
Antiplatelet Removal and HemocompatIbility EventS With the HeartMate 3 Pump IDE Study
Enrollment Status: Completed
Publish Date: March 27, 2025
Intervention Type: Drug, Device
Study Phase: Not Applicable
View 1 Less Clinical Trial

101 Total Publications

Low-dose apixaban in HeartMate 3 LVAD patients, interim analysis of the ApixiVAD trial, a randomized controlled study.
Low-dose apixaban in HeartMate 3 LVAD patients, interim analysis of the ApixiVAD trial, a randomized controlled study.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: February 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Jansz's expertise for a condition
ConditionClose
    View All 14 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile